Florine A. Eggink

1.1k total citations
15 papers, 830 citations indexed

About

Florine A. Eggink is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Florine A. Eggink has authored 15 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 8 papers in Reproductive Medicine and 7 papers in Oncology. Recurrent topics in Florine A. Eggink's work include Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Florine A. Eggink is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Florine A. Eggink collaborates with scholars based in Netherlands, United Kingdom and France. Florine A. Eggink's co-authors include Hans W. Nijman, Marco de Bruyn, Carien L. Creutzberg, Tjalling Bosse, David N. Church, Inge C. van Gool, Luke Freeman-Mills, Maartje C.A. Wouters, Fenne L. Komdeur and Annechien Plat and has published in prestigious journals such as Clinical Cancer Research, European Journal of Cancer and Oncotarget.

In The Last Decade

Florine A. Eggink

15 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florine A. Eggink Netherlands 11 491 357 291 201 141 15 830
Robert Orlowski United States 11 399 0.8× 108 0.3× 279 1.0× 215 1.1× 160 1.1× 35 673
Raquel Bratos Spain 8 327 0.7× 68 0.2× 222 0.8× 229 1.1× 92 0.7× 13 609
Hiroaki Kase Japan 16 94 0.2× 159 0.4× 448 1.5× 453 2.3× 81 0.6× 35 834
Steven DeCesare United States 9 243 0.5× 80 0.2× 260 0.9× 240 1.2× 86 0.6× 13 695
Eriko Yokoi Japan 16 329 0.7× 258 0.7× 172 0.6× 102 0.5× 11 0.1× 24 588
Naoko Komura Japan 16 344 0.7× 283 0.8× 97 0.3× 105 0.5× 12 0.1× 35 560
Richard A. Boothby United States 6 323 0.7× 60 0.2× 108 0.4× 291 1.4× 120 0.9× 7 600
Ulrich Canzler Germany 13 226 0.5× 71 0.2× 196 0.7× 528 2.6× 72 0.5× 48 683
Siel Olbrecht Belgium 7 212 0.4× 69 0.2× 94 0.3× 294 1.5× 30 0.2× 13 502
Elisabeth Janschek Austria 10 318 0.6× 31 0.1× 173 0.6× 200 1.0× 73 0.5× 17 687

Countries citing papers authored by Florine A. Eggink

Since Specialization
Citations

This map shows the geographic impact of Florine A. Eggink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florine A. Eggink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florine A. Eggink more than expected).

Fields of papers citing papers by Florine A. Eggink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florine A. Eggink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florine A. Eggink. The network helps show where Florine A. Eggink may publish in the future.

Co-authorship network of co-authors of Florine A. Eggink

This figure shows the co-authorship network connecting the top 25 collaborators of Florine A. Eggink. A scholar is included among the top collaborators of Florine A. Eggink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florine A. Eggink. Florine A. Eggink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Weelden, Willem Jan van, Casper Reijnen, Florine A. Eggink, et al.. (2020). Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study. European Journal of Cancer. 133. 104–111. 20 indexed citations
2.
Paijens, Sterre T., Maartje C.A. Wouters, Fenne L. Komdeur, et al.. (2020). Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome. OncoImmunology. 9(1). 1760705–1760705. 26 indexed citations
3.
Workel, Hagma H., Joyce M. Lubbers, Roland Arnold, et al.. (2019). A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunology Research. 7(5). 784–796. 167 indexed citations
4.
Ezendam, Nicole P. M., Florine A. Eggink, Dennis van Hamont, et al.. (2018). Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade. Gynecological Surgery. 15(1). 7–7. 5 indexed citations
5.
Eggink, Florine A., Inge C. van Gool, Alexandra Léary, et al.. (2017). Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. Data Archiving and Networked Services (DANS). 17 indexed citations
6.
Eggink, Florine A., Constantijne H. Mom, Dorry Boll, et al.. (2017). Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification. European Journal of Cancer. 78. 82–90. 6 indexed citations
7.
Eggink, Florine A., Corine M. Koopmans, & Hans W. Nijman. (2017). Surgery for patients with newly diagnosed advanced ovarian cancer: which patient, when and extent?. Current Opinion in Oncology. 29(5). 351–358. 9 indexed citations
8.
Eggink, Florine A., et al.. (2017). The impact of centralization of services on treatment delay in ovarian cancer: A study on process quality. International Journal for Quality in Health Care. 29(6). 810–816. 7 indexed citations
9.
Eggink, Florine A., Constantijne H. Mom, Dorry Boll, et al.. (2017). Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients. Gynecologic Oncology. 146(2). 380–385. 15 indexed citations
10.
Eggink, Florine A., Constantijne H. Mom, Roy F.P.M. Kruitwagen, et al.. (2016). Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands. Gynecologic Oncology. 141(3). 524–530. 25 indexed citations
11.
Workel, Hagma H., Fenne L. Komdeur, Maartje C.A. Wouters, et al.. (2016). CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. European Journal of Cancer. 60. 1–11. 113 indexed citations
12.
Komdeur, Fenne L., Maartje C.A. Wouters, Hagma H. Workel, et al.. (2016). CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 7(46). 75130–75144. 64 indexed citations
13.
Eggink, Florine A., Inge C. van Gool, Alexandra Léary, et al.. (2016). Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. OncoImmunology. 6(2). e1264565–e1264565. 101 indexed citations
14.
Gool, Inge C. van, Florine A. Eggink, Luke Freeman-Mills, et al.. (2015). POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. Clinical Cancer Research. 21(14). 3347–3355. 231 indexed citations
15.
Eggink, Florine A., Luke Freeman-Mills, Ellen Stelloo, et al.. (2015). 207 POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer. European Journal of Cancer. 51. S29–S29. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026